Bone morphogenetic protein-2 provokes interleukin-18-induced human intervertebral disc degeneration.
OBJECTIVE
Interleukin 18 (IL-18) is a regulatory cytokine that degrades the disc matrix. Bone morphogenetic protein-2 (BMP-2) stimulates synthesis of the disc extracellular matrix. However, the combined effects of BMP-2 and IL-18 on human intervertebral disc degeneration have not previously been reported. The aim of this study was to investigate the effects of the anabolic cytokine BMP-2 and the catabolic cytokine IL-18 on human nucleus pulposus (NP) and annulus fibrosus (AF) cells and, therefore, to identify potential therapeutic and clinical benefits of recombinant human (rh)BMP-2 in intervertebral disc degeneration.


METHODS
Levels of IL-18 were measured in the blood of patients with intervertebral disc degenerative disease and in control patients. Human NP and AF cells were cultured in a NP cell medium and treated with IL-18 or IL-18 plus BMP-2. mRNA levels of target genes were measured by real-time polymerase chain reaction, and protein levels of aggrecan, type II collagen, SOX6, and matrix metalloproteinase 13 (MMP13) were assessed by western blot analysis.


RESULTS
The serum level of patients (IL-18) increased significantly with the grade of IVD degeneration. There was a dramatic alteration in IL-18 level between the advanced degeneration (Grade III to V) group and the normal group (p = 0.008) Furthermore, IL-18 induced upregulation of the catabolic regulator MMP13 and downregulation of the anabolic regulators aggrecan, type II collagen, and SOX6 at 24 hours, contributing to degradation of disc matrix enzymes. However, BMP-2 antagonised the IL-18 induced upregulation of aggrecan, type II collagen, and SOX6, resulting in reversal of IL-18 mediated disc degeneration.


CONCLUSIONS
BMP-2 is anti-catabolic in human NP and AF cells, and its effects are partially mediated through provocation of the catabolic effect of IL-18. These findings indicate that BMP-2 may be a unique therapeutic option for prevention and reversal of disc degeneration.Cite this article: S. Ye, B. Ju, H. Wang, K-B. Lee. Bone morphogenetic protein-2 provokes interleukin-18-induced human intervertebral disc degeneration. Bone Joint Res 2016;5:412-418. DOI: 10.1302/2046-3758.59.BJR-2016-0032.R1.
Department of Orthopaedic Surgery, Chonbuk National University Medical School, Research Institute of Clinical Medicine of Chonbuk National University-Biomedical Research, Institute of Chonbuk National University Hospital, Jeonju, Korea.
S
S
Ye
Department of Orthopaedic Surgery, Chonbuk National University Medical School, Research Institute of Clinical Medicine of Chonbuk National University-Biomedical Research, Institute of Chonbuk National University Hospital, Jeonju, Korea.
B
B
Ju
Chonbuk National University Medical School, Research Institute of Clinical Medicine of Chonbuk National University-Biomedical Research, Institute of Chonbuk National University Hospital, Jeonju, Korea.
H
H
Wang
Department of Orthopaedic Surgery, Chonbuk National University Medical School, Research Institute of Clinical Medicine of Chonbuk National University-Biomedical Research, Institute of Chonbuk National University Hospital, Jeonju, Korea osdr2815@naver.com.
K-B
KB
Lee
Bone morphogenetic protein-2 (BMP-2); Interleukin-18 (IL-18); Intervertebral disc degeneration (IVD); Nucleus pulposus and annulus fibrosus cells
Nat Rev Rheumatol. 2011 Jan;7(1):33-42
21119608
Spine (Phila Pa 1976). 2002 Jun 15;27(12):1318-25
12065981
Spine J. 2004 Nov-Dec;4(6 Suppl):330S-340S
15541686
Spine (Phila Pa 1976). 2004 Oct 1;29(19):2091-5
15454697
Eur Spine J. 2006 May;15(5):588-96
15980999
Spine (Phila Pa 1976). 2000 Feb 15;25(4):487-92
10707396
Spine (Phila Pa 1976). 2009 Aug 1;34(17):1834-8
19644335
J Orthop Res. 2011 Feb;29(2):265-9
20690185
Int J Obes (Lond). 2005 Aug;29(8):903-8
15917859
Spine (Phila Pa 1976). 2006 Jul 15;31(16):1770-4
16845348
Arthritis Res Ther. 2008;10(2):R48
18435858
Clin Biochem. 2009 Oct;42(15):1504-11
19563795
Spine (Phila Pa 1976). 2011 Aug 1;36(17):1333-9
21217432
Int J Mol Sci. 2014 May 14;15(5):8539-52
24830556
J Spinal Disord Tech. 2004 Oct;17(5):423-8
15385883
Bone Joint J. 2014 Jan;96-B(1):31-5
24395307
Spine (Phila Pa 1976). 2003 Mar 1;28(5):446-54; discussion 453
12616155
Bone Joint J. 2015 Jul;97-B(7):997-1003
26130359
Expert Rev Mol Med. 2001 Mar 29;2001:1-10
14987359
J Orthop Res. 2003 Sep;21(5):922-30
12919882
J Spinal Disord Tech. 2006 Jun;19(4):266-9
16778661
J Dent Res. 2014 Apr;93(4):335-45
24389809
Eur Spine J. 2002 Feb;11(1):62-6
11931066
Cell Biol Int. 2001;25(7):679-89
11448107
Spine (Phila Pa 1976). 2008 Apr 15;33(8):831-8
18404100